ℹ️ Skipped - page is already crawled
| Filter | Status | Condition | Details |
|---|---|---|---|
| HTTP status | PASS | download_http_code = 200 | HTTP 200 |
| Age cutoff | PASS | download_stamp > now() - 6 MONTH | 0 months ago |
| History drop | PASS | isNull(history_drop_reason) | No drop reason |
| Spam/ban | PASS | fh_dont_index != 1 AND ml_spam_score = 0 | ml_spam_score=0 |
| Canonical | PASS | meta_canonical IS NULL OR = '' OR = src_unparsed | Not set |
| Property | Value |
|---|---|
| URL | https://www.novartis.com/careers |
| Last Crawled | 2026-04-09 20:46:52 (7 hours ago) |
| First Indexed | 2015-06-16 00:19:48 (10 years ago) |
| HTTP Status Code | 200 |
| Meta Title | Careers | Novartis |
| Meta Description | Search for careers at Novartis and discover our diverse and inclusive teams where we collaborate to bring innovative products to life. |
| Meta Canonical | null |
| Boilerpipe Text | Function
Location
Division
Show Filters
Date Posted
Date Posted
Welcome to where we
thrive together
Improving the lives of people living with disease takes more than innovative science. It takes a focus on the needs of people and a community committed to meeting them. It takes a team of people like you. Working together. Learning together. Thriving together. Discover how you can join us in changing people’s lives.
Our business functions
Learn more about our teams – what they do, how they work and where you could make a difference.
Work with purpose
Chasing breakthroughs, transforming processes, or building partnerships - what you do here makes a difference.
Personal growth
You'll have countless opportunities to develop, whether it’s up, across or outside your comfort zone.
Mental health
Access advice and support to help you be your best self.
“How do I grow? By sharing knowledge, ideas, and inspiration everyday with my incredible colleagues around the globe.”
Dalia
, Head Data Science, Analytics and AI
Benefits and rewards
Here is a glimpse of just some ways we’ll help you thrive personally and professionally.
Specifics may vary by location
Latest stories
Unique insights and perspectives from people across Novartis.
Join our talent community
Be first to hear about our latest career opportunities, news and events.
Be aware of fake job advertisements and job offers
Novartis is aware of employment scams which make false use of our company name or leader’s names to defraud job seekers. Novartis does not make job offers without interview and never asks candidates for money.
If you have encountered a job posting or been approached with a job offer that you suspect may be fraudulent, we strongly recommend you do not respond, send money or personal information.
Novartis in not responsible for any claims, losses, damages, or expenses resulting from scams.
Follow Novartis careers
Keep up with everything careers-related via our dedicated social media channels. |
| Markdown | [Skip to main content](https://www.novartis.com/careers#main)
[ ](https://www.novartis.com/)
-   Search

Global \| **en**
Choose Location
- [**International**](https://www.novartis.com/careers#international)
- [**Americas**](https://www.novartis.com/careers#americas)
- [**Asia Pacific**](https://www.novartis.com/careers#asia-pacific)
- [**Europe**](https://www.novartis.com/careers#europe)
- [**Middle East & Africa**](https://www.novartis.com/careers#middle-east---africa)
[Global \| **English**](https://www.novartis.com/)
[Novartis Foundation \| **English**](https://www.novartisfoundation.org/)
[Argentina \| **Español**](https://www.novartis.com/ar-es/)
[Brazil \| **Português**](https://www.novartis.com/br-pt/)
[Canada \| **English**](https://www.novartis.com/ca-en/)
[Canada \| **Français**](https://www.novartis.com/ca-fr/)
[Andean & CAC \| **Español**](https://www.novartis.com/acc-es/)
[Colombia \| **Español**](https://www.novartis.com/co-es/)
[Mexico \| **Español**](https://www.novartis.com/mx-es/)
[United States \| **English**](https://www.novartis.com/us-en/)
[Australia \| **English**](https://www.novartis.com/au-en/)
[Hong Kong S.A.R. \| **繁體中文**](https://www.novartis.com/hk-zh/)
[India \| **English**](https://www.novartis.com/in-en/)
[Indonesia \| **English**](https://www.novartis.com/id-en/)
[Japan \| **日本語**](https://www.novartis.com/jp-ja/)
[Korea \| **한국어**](https://www.novartis.com/kr-ko/)
[Mainland China \| **中文**](https://www.novartis.com.cn/)
[Malaysia \| **English**](https://www.novartis.com/my-en/)
[Philippines \| **English**](https://www.novartis.com/ph-en/)
[Singapore \| **English**](https://www.novartis.com/sg-en/)
[Taiwan \| **繁體中文**](https://www.novartis.com/tw-zh/)
[Thailand \| **ภาษาไทย**](https://www.novartis.com/th-th/)
[Austria \| **Deutsch**](https://www.novartis.com/at-de/)
[Belgium \| **Français**](https://www.novartis.com/be-fr/)
[Belgium \| **Nederlands**](https://www.novartis.com/be-nl/)
[Bulgaria \| **Български**](https://www.novartis.com/bg-bg/)
[Czech Republic \| **Česky**](https://www.novartis.com/cz-cs/)
[Czech Republic \| **English**](https://www.novartis.com/cz-en/)
[Denmark \| **Dansk**](https://www.novartis.com/dk-da/)
[Estonia \| **Eesti**](https://www.novartis.com/ee-et/)
[Finland \| **Suomalainen**](https://www.novartis.com/fi-fi/)
[France \| **Français**](https://www.novartis.com/fr-fr/)
[Germany \| **Deutsch**](https://www.novartis.com/de-de/)
[Greece \| **Ελληνικά**](https://www.novartis.com/gr-el/)
[Hungary \| **Magyar**](https://www.novartis.com/hu-hu/)
[Ireland \| **English**](https://www.novartis.com/ie-en/)
[Italy \| **Italiano**](https://www.novartis.com/it-it/)
[Latvia \| **Latvian**](https://www.novartis.com/lv-lv/)
[Lithuania \| **Lithuanian**](https://www.novartis.com/lt-lt/)
[Netherlands \| **Nederlands**](https://www.novartis.com/nl-nl/)
[Norway \| **Norsk**](https://www.novartis.com/no-no/)
[Poland \| **Polski**](https://www.novartis.com/pl-pl/)
[Portugal \| **Português**](https://www.novartis.com/pt-pt/)
[Romania \| **Română**](https://www.novartis.com/ro-ro/)
[Russia \| **Русский**](https://www.novartis.com/ru-ru/)
[Serbia \| **Srpski**](https://www.novartis.com/rs-sr/)
[Slovakia \| **Slovensky**](https://www.novartis.com/sk-sk/)
[Slovenia \| **Slovenščina**](https://www.novartis.com/si-sl/)
[Slovenia \| **English**](https://www.novartis.com/si-en/)
[Spain \| **Español**](https://www.novartis.com/es-es/)
[Sweden \| **Svenska**](https://www.novartis.com/se-se/)
[Switzerland \| **Deutsch**](https://www.novartis.com/ch-de/)
[Switzerland \| **Français**](https://www.novartis.com/ch-fr/)
[Türkiye \| **Türkçe**](https://www.novartis.com/tr-tr/)
[Ukraine \| **українська**](https://www.novartis.com/ua-uk/)
[United Kingdom \| **English**](https://www.novartis.com/uk-en/)
[Egypt \| **English**](https://www.novartis.com/eg-en/)
[Israel \| **עברית**](https://www.novartis.com/il-he/)
[Saudi Arabia \| **العربية**](https://www.novartis.com/sa-ar/)
[South Africa \| **English**](https://www.novartis.com/za-en/)

Global
Choose Location
****international****
[International](https://www.novartis.com/careers#international) [Americas](https://www.novartis.com/careers#americas) [Asia Pacific](https://www.novartis.com/careers#asia-pacific) [Europe](https://www.novartis.com/careers#europe) [Middle East & Africa](https://www.novartis.com/careers#middle-east---africa)
[Argentina \| **Español**](https://www.novartis.com/ar-es/)
[Australia \| **English**](https://www.novartis.com/au-en/)
[Austria \| **Deutsch**](https://www.novartis.com/at-de/)
[Belgium \| **Français**](https://www.novartis.com/be-fr/)
[Belgium \| **Nederlands**](https://www.novartis.com/be-nl/)
[Brazil \| **Português**](https://www.novartis.com/br-pt/)
[Bulgaria \| **Български**](https://www.novartis.com/bg-bg/)
[Canada \| **English**](https://www.novartis.com/ca-en/)
[Canada \| **Français**](https://www.novartis.com/ca-fr/)
[Andean & CAC \| **Español**](https://www.novartis.com/acc-es/)
[Colombia \| **Español**](https://www.novartis.com/co-es/)
[Czech Republic \| **Česky**](https://www.novartis.com/cz-cs/)
[Czech Republic \| **English**](https://www.novartis.com/cz-en/)
[Denmark \| **Dansk**](https://www.novartis.com/dk-da/)
[Egypt \| **English**](https://www.novartis.com/eg-en/)
[Estonia \| **Eesti**](https://www.novartis.com/ee-et/)
[Finland \| **Suomalainen**](https://www.novartis.com/fi-fi/)
[France \| **Français**](https://www.novartis.com/fr-fr/)
[Germany \| **Deutsch**](https://www.novartis.com/de-de/)
[Greece \| **Ελληνικά**](https://www.novartis.com/gr-el/)
[Hong Kong S.A.R. \| **繁體中文**](https://www.novartis.com/hk-zh/)
[Hungary \| **Magyar**](https://www.novartis.com/hu-hu/)
[India \| **English**](https://www.novartis.com/in-en/)
[Indonesia \| **English**](https://www.novartis.com/id-en/)
[Ireland \| **English**](https://www.novartis.com/ie-en/)
[Israel \| **עברית**](https://www.novartis.com/il-he/)
[Italy \| **Italiano**](https://www.novartis.com/it-it/)
[Japan \| **日本語**](https://www.novartis.com/jp-ja/)
[Korea \| **한국어**](https://www.novartis.com/kr-ko/)
[Latvia \| **Latvian**](https://www.novartis.com/lv-lv/)
[Lithuania \| **Lithuanian**](https://www.novartis.com/lt-lt/)
[Mainland China \| **中文**](https://www.novartis.com.cn/)
[Malaysia \| **English**](https://www.novartis.com/my-en/)
[Mexico \| **Español**](https://www.novartis.com/mx-es/)
[Netherlands \| **Nederlands**](https://www.novartis.com/nl-nl/)
[Norway \| **Norsk**](https://www.novartis.com/no-no/)
[Global \| **English**](https://www.novartis.com/)
[Novartis Foundation \| **English**](https://www.novartisfoundation.org/)
[Philippines \| **English**](https://www.novartis.com/ph-en/)
[Poland \| **Polski**](https://www.novartis.com/pl-pl/)
[Portugal \| **Português**](https://www.novartis.com/pt-pt/)
[Romania \| **Română**](https://www.novartis.com/ro-ro/)
[Russia \| **Русский**](https://www.novartis.com/ru-ru/)
[Saudi Arabia \| **العربية**](https://www.novartis.com/sa-ar/)
[Serbia \| **Srpski**](https://www.novartis.com/rs-sr/)
[Singapore \| **English**](https://www.novartis.com/sg-en/)
[Slovakia \| **Slovensky**](https://www.novartis.com/sk-sk/)
[Slovenia \| **Slovenščina**](https://www.novartis.com/si-sl/)
[Slovenia \| **English**](https://www.novartis.com/si-en/)
[South Africa \| **English**](https://www.novartis.com/za-en/)
[Spain \| **Español**](https://www.novartis.com/es-es/)
[Sweden \| **Svenska**](https://www.novartis.com/se-se/)
[Switzerland \| **Deutsch**](https://www.novartis.com/ch-de/)
[Switzerland \| **Français**](https://www.novartis.com/ch-fr/)
[Taiwan \| **繁體中文**](https://www.novartis.com/tw-zh/)
[Thailand \| **ภาษาไทย**](https://www.novartis.com/th-th/)
[Türkiye \| **Türkçe**](https://www.novartis.com/tr-tr/)
[Ukraine \| **українська**](https://www.novartis.com/ua-uk/)
[United Kingdom \| **English**](https://www.novartis.com/uk-en/)
[United States \| **English**](https://www.novartis.com/us-en/)
- Menu
- [About](https://www.novartis.com/about "About")
- [Board of Directors](https://www.novartis.com/about/board-directors "Board of Directors")
- [Giovanni Caforio](https://www.novartis.com/about/board-directors/giovanni-caforio "Giovanni Caforio")
- [Simon Moroney](https://www.novartis.com/about/board-directors/simon-moroney "Simon Moroney")
- [Nancy C. Andrews](https://www.novartis.com/about/board-directors/nancy-c-andrews "Nancy C. Andrews")
- [Ton Buechner](https://www.novartis.com/about/board-directors/ton-buechner "Ton Buechner")
- [Patrice Bula](https://www.novartis.com/about/board-directors/patrice-bula "Patrice Bula")
- [Elizabeth (Liz) Doherty](https://www.novartis.com/about/board-directors/elizabeth-liz-doherty "Elizabeth (Liz) Doherty")
- [Bridgette Heller](https://www.novartis.com/about/board-directors/bridgette-heller "Bridgette Heller")
- [Frans van Houten](https://www.novartis.com/about/board-directors/frans-van-houten "Frans van Houten")
- [Elizabeth McNally](https://www.novartis.com/about/board-directors/elizabeth-mcnally "Elizabeth McNally")
- [Ana de Pro Gonzalo](https://www.novartis.com/about/board-directors/ana-de-pro-gonzalo "Ana de Pro Gonzalo")
- [Charles Swanton](https://www.novartis.com/about/board-directors/charles-swanton "Charles Swanton")
- [John D. Young](https://www.novartis.com/about/board-directors/john-d-young "John D. Young")
- [Charlotte Pamer-Wieser](https://www.novartis.com/about/board-directors/charlotte-pamer-wieser "Charlotte Pamer-Wieser")
- [Executive Committee](https://www.novartis.com/about/executive-committee "Executive Committee")
- [Vasant (Vas) Narasimhan](https://www.novartis.com/about/executive-committee/vasant-narasimhan "Vasant (Vas) Narasimhan")
- [Shreeram Aradhye](https://www.novartis.com/about/executive-committee/shreeram-aradhye "Shreeram Aradhye")
- [Victor Bulto](https://www.novartis.com/about/executive-committee/victor-bulto "Victor Bulto")
- [Aharon (Ronny) Gal](https://www.novartis.com/about/executive-committee/aharon-ronny-gal-phd "Aharon (Ronny) Gal")
- [Karen L. Hale](https://www.novartis.com/about/executive-committee/karen-hale "Karen L. Hale")
- [Patrick Horber](https://www.novartis.com/about/executive-committee/patrick-horber-md "Patrick Horber")
- [Rob Kowalski](https://www.novartis.com/about/executive-committee/rob-kowalski "Rob Kowalski")
- [Steffen Lang](https://www.novartis.com/about/executive-committee/steffen-lang "Steffen Lang")
- [Fiona Marshall](https://www.novartis.com/about/executive-committee/fiona-marshall "Fiona Marshall")
- [Mukul Mehta](https://www.novartis.com/about/executive-committee/mukul-mehta "Mukul Mehta")
- [Lutz Hegemann](https://www.novartis.com/about/executive-committee/lutz-hegemann "Lutz Hegemann")
- [Teresa Jose](https://www.novartis.com/about/executive-committee/teresa-jose "Teresa Jose")
- [Michelle Weese](https://www.novartis.com/about/executive-committee/michelle-weese "Michelle Weese")
- [Products](https://www.novartis.com/about/products "Products")
- [Therapeutic areas](https://www.novartis.com/about/therapeutic-areas "Therapeutic areas")
- [Cardiovascular, renal and metabolic](https://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic "Cardiovascular, renal and metabolic")
- [Immunology](https://www.novartis.com/about/therapeutic-areas/immunology "Immunology")
- [Neuroscience](https://www.novartis.com/about/therapeutic-areas/neuroscience "Neuroscience")
- [Oncology](https://www.novartis.com/about/therapeutic-areas/oncology "Oncology")
- [People and culture](https://www.novartis.com/about/people-and-culture "People and culture")
- [Inclusion](https://www.novartis.com/about/inclusion "Inclusion")
- [Promoting inclusion](https://www.novartis.com/about/inclusion/promoting-inclusion "Promoting inclusion")
- [Building belonging](https://www.novartis.com/about/inclusion/building-belonging "Building belonging")
- [Parental leave](https://www.novartis.com/about/inclusion/parental-leave "Parental leave")
- [Caring for the mental health and wellbeing of our people](https://www.novartis.com/about/inclusion/caring-mental-health-and-wellbeing-our-people "Caring for the mental health and wellbeing of our people")
- [Novartis Gene Therapies](https://www.novartis.com/about/novartis-gene-therapies "Novartis Gene Therapies")
- [Manufacturing](https://www.novartis.com/about/manufacturing "Manufacturing")
- [Quality](https://www.novartis.com/about/quality "Quality")
- [Novartis quality management system (QMS)](https://www.novartis.com/about/quality/novartis-quality-management-system-qms "Novartis quality management system (QMS)")
- [Audit program and regulatory inspections](https://www.novartis.com/about/quality/audit-program-and-regulatory-inspections "Audit program and regulatory inspections")
- [Product and patient safety training](https://www.novartis.com/about/quality/product-and-patient-safety-training "Product and patient safety training")
- [Product recalls](https://www.novartis.com/about/quality/product-recalls "Product recalls")
- [Third-party suppliers](https://www.novartis.com/about/quality/third-party-suppliers "Third-party suppliers")
- [Novartis and the European Union (EU)](https://www.novartis.com/about/novartis-and-european-union "Novartis and the European Union (EU)")
- [Awards and recognition](https://www.novartis.com/about/awards-and-recognition "Awards and recognition")

About
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach 296 million people worldwide.
- [Patients and caregivers](https://www.novartis.com/patients-and-caregivers "Patients and caregivers")
- [Novartis commitment to patients and caregivers](https://www.novartis.com/patients-and-caregivers/novartis-commitment-patients-and-caregivers "Novartis commitment to patients and caregivers")
- [Diseases](https://www.novartis.com/diseases "Diseases")
- [Patient organization funding](https://www.novartis.com/investors/reporting-and-transparency-hub/patient-organization-funding "Patient organization funding")
- [Patients perspectives stories](https://www.novartis.com/news/stories/patient-perspectives "Patients perspectives stories")

Patients and caregivers
Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.
- [Healthcare professionals](https://www.novartis.com/healthcare-professionals "Healthcare professionals")
- [Medical congresses and events](https://www.novartis.com/healthcare-professionals/medical-congresses-and-events "Medical congresses and events")
- [ASCO Annual Meeting](https://www.novartis.com/healthcare-professionals/medical-congresses-and-events/asco-annual-meeting "ASCO Annual Meeting")
- [ASCO 2023](https://www.novartis.com/healthcare-professionals/medical-congresses-and-events/asco-annual-meeting/asco-2023 "ASCO 2023")
- [Products](https://www.novartis.com/about/products "Products")
- [Novartis pipeline](https://www.novartis.com/research-development/novartis-pipeline "Novartis pipeline")
- [Managed Access Programs](https://www.novartis.com/healthcare-professionals/managed-access-programs "Managed Access Programs")
- [Zolgensma® Global Managed Access Program (gMAP)](https://www.novartis.com/healthcare-professionals/managed-access-programs/zolgensma-global-managed-access-program-gmap "Zolgensma® Global Managed Access Program (gMAP)")
- [Novartis external funding](https://www.novartis.com/healthcare-professionals/novartis-external-funding "Novartis external funding")
- [Healthcare professional resources by country](https://www.novartis.com/healthcare-professionals/healthcare-professional-resources-country "Healthcare professional resources by country")
- [Investigator-initiated trials / studies](https://www.novartis.com/healthcare-professionals/investigator-initiated-trials-studies-clinical-and-investigator-initiated-research-non-clinical "Investigator-initiated trials / studies")
- [Novartis medical information](https://www.novartis.com/healthcare-professionals/novartis-medical-information "Novartis medical information")
- [Submit medical enquiry](https://www.novartis.com/healthcare-professionals/novartis-medical-information/submit-medical-enquiry "Submit medical enquiry")
- [Payments to Healthcare Professionals](https://www.novartis.com/healthcare-professionals/payments-healthcare-professionals "Payments to Healthcare Professionals")

Healthcare professionals
Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.
- [Research and development](https://www.novartis.com/research-and-development "Research and development")
- [Technology platforms](https://www.novartis.com/research-and-development/technology-platforms "Technology platforms")
- [Research disease areas](https://www.novartis.com/research-and-development/research-disease-areas "Research disease areas")
- [Cardiovascular and metabolic disease research at Novartis](https://www.novartis.com/research-and-development/research-disease-areas/cardiovascular-and-metabolic-disease-research-novartis "Cardiovascular and metabolic disease research at Novartis")
- [Diseases of Aging and Regenerative medicine (DARe)](https://www.novartis.com/research-and-development/research-disease-areas/diseases-aging-and-regenerative-medicine-dare-research-novartis "Diseases of Aging and Regenerative medicine (DARe)")
- [DAx: exploratory disease research at Novartis](https://www.novartis.com/research-and-development/research-disease-areas/dax-exploratory-disease-research-novartis "DAx: exploratory disease research at Novartis")
- [Global Health disease area research at Novartis](https://www.novartis.com/research-and-development/research-disease-areas/global-health-disease-area-research-novartis "Global Health disease area research at Novartis")
- [Immunology disease research at Novartis](https://www.novartis.com/research-and-development/research-disease-areas/immunology-disease-research-novartis "Immunology disease research at Novartis")
- [Neuroscience research at Novartis](https://www.novartis.com/research-and-development/research-disease-areas/neuroscience-research-novartis "Neuroscience research at Novartis")
- [Oncology research at Novartis](https://www.novartis.com/research-and-development/research-disease-areas/oncology-research-novartis "Oncology research at Novartis")
- [Novartis pipeline](https://www.novartis.com/research-development/novartis-pipeline "Novartis pipeline")
- [Research collaborations](https://www.novartis.com/research-and-development/research-collaborations "Research collaborations")
- [Collaborations](https://www.novartis.com/research-and-development/collaborations "Collaborations")

Research & development
Discover how Novartis turns breakthrough science into transformative, high-value treatments.
- [ESG](https://www.novartis.com/esg "ESG")
- [Access](https://www.novartis.com/esg/access "Access")
- [Creating sustainable business models](https://www.novartis.com/esg/access/creating-sustainable-business-models "Creating sustainable business models")
- [Value-based pricing](https://www.novartis.com/esg/access/value-based-pricing "Value-based pricing")
- [Sub-Saharan Africa](https://www.novartis.com/esg/access/sub-saharan-africa "Sub-Saharan Africa")
- [Donations](https://www.novartis.com/esg/access/donations "Donations")
- [Novartis access principles](https://www.novartis.com/esg/access/novartis-access-principles "Novartis access principles")
- [Novartis oncology access](https://www.novartis.com/esg/access/novartis-oncology-access "Novartis oncology access")
- [Patents and licensing](https://www.novartis.com/esg/access/patents-and-licensing "Patents and licensing")
- [Environmental sustainability](https://www.novartis.com/esg/environmental-sustainability "Environmental sustainability")
- [Nature](https://www.novartis.com/esg/environmental-sustainability/nature "Nature")
- [Climate](https://www.novartis.com/esg/environmental-sustainability/climate "Climate")
- [Ethics, risk and compliance](https://www.novartis.com/esg/ethics-risk-and-compliance "Ethics, risk and compliance")
- [Ethical behavior](https://www.novartis.com/esg/ethics-risk-and-compliance/ethical-behavior "Ethical behavior")
- [Compliance](https://www.novartis.com/esg/ethics-risk-and-compliance/compliance "Compliance")
- [Human rights](https://www.novartis.com/esg/ethics-risk-and-compliance/human-rights "Human rights")
- [Learning and engagement](https://www.novartis.com/esg/ethics-risk-and-compliance/learning-and-engagement "Learning and engagement")
- [Integrated risk assurance](https://www.novartis.com/esg/ethics-risk-and-compliance/integrated-risk-assurance "Integrated risk assurance")
- [Global health](https://www.novartis.com/esg/global-health "Global health")
- [Pandemic preparedness](https://www.novartis.com/esg/global-health/pandemic-preparedness "Pandemic preparedness")
- [Chagas disease](https://www.novartis.com/diseases/chagas-disease "Chagas disease")
- [Leprosy](https://www.novartis.com/diseases/leprosy "Leprosy")
- [Malaria](https://www.novartis.com/diseases/malaria "Malaria")
- [Sickle cell disease (SCD)](https://www.novartis.com/diseases/sickle-cell-disease "Sickle cell disease (SCD)")
- [Novartis Foundation](https://www.novartisfoundation.org/ "Novartis Foundation")
- [Inclusion](https://www.novartis.com/about/inclusion "Inclusion")
- [ESG index](https://www.novartis.com/esg/index "ESG index")
- [Reporting and transparency hub](https://www.novartis.com/investors/reporting-and-transparency-hub "Reporting and transparency hub")
- [ESG rating performance](https://www.novartis.com/investors/reporting-and-transparency-hub/esg-rating-performance "ESG rating performance")
- [Patient organization funding](https://www.novartis.com/investors/reporting-and-transparency-hub/patient-organization-funding "Patient organization funding")
- [Payments to healthcare professionals](https://www.novartis.com/healthcare-professionals/payments-healthcare-professionals "Payments to healthcare professionals")
- [Public policy](https://www.novartis.com/investors/reporting-and-transparency-hub/public-policy "Public policy")
- [Animal research](https://www.novartis.com/investors/reporting-and-transparency-hub/animal-research "Animal research")

Environmental, social and governance
Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards.
- [Investors](https://www.novartis.com/investors "Investors")
- [Event calendar](https://www.novartis.com/investors/event-calendar "Event calendar")
- [Financial data](https://www.novartis.com/investors/financial-data "Financial data")
- [Novartis annual results](https://www.novartis.com/investors/financial-data/annual-results "Novartis annual results")
- [Novartis quarterly results](https://www.novartis.com/investors/financial-data/quarterly-results "Novartis quarterly results")
- [Novartis SEC filings](https://www.novartis.com/investors/financial-data/sec-filings "Novartis SEC filings")
- [Product sales](https://www.novartis.com/investors/financial-data/product-sales "Product sales")
- [Fixed-income securities](https://www.novartis.com/investors/financial-data/fixed-income-securities "Fixed-income securities")
- [Expected currency impact](https://www.novartis.com/investors/financial-data/expected-currency-impact "Expected currency impact")
- [Share data and analysis](https://www.novartis.com/investors/share-data-and-analysis "Share data and analysis")
- [Share monitor](https://www.novartis.com/investors/share-data-and-analysis/share-monitor "Share monitor")
- [Dividend information](https://www.novartis.com/investors/share-data-and-analysis/dividend-information "Dividend information")
- [Share ownership](https://www.novartis.com/investors/share-data-and-analysis/share-ownership "Share ownership")
- [Share overview](https://www.novartis.com/investors/share-data-and-analysis/share-overview "Share overview")
- [Return on investment calculator](https://www.novartis.com/investors/share-data-and-analysis/return-investment-calculator "Return on investment calculator")
- [Shareholder information](https://www.novartis.com/investors/shareholder-information "Shareholder information")
- [General Meetings](https://www.novartis.com/investors/shareholder-information/general-meetings "General Meetings")
- [American Depositary Receipts (ADR)](https://www.novartis.com/investors/shareholder-information/american-depositary-receipts-adr "American Depositary Receipts (ADR)")
- [Share buyback](https://www.novartis.com/investors/shareholder-information/share-buy-back "Share buyback")
- [Frequently asked questions](https://www.novartis.com/investors/shareholder-information/frequently-asked-questions "Frequently asked questions")
- [Company overview](https://www.novartis.com/investors/company-overview "Company overview")
- [Corporate governance](https://www.novartis.com/investors/company-overview/corporate-governance "Corporate governance")
- [Reporting and transparency hub](https://www.novartis.com/investors/reporting-and-transparency-hub "Reporting and transparency hub")
- [Reporting archive](https://www.novartis.com/investors/reporting-and-transparency-hub/reporting-archive "Reporting archive")
- [ESG rating performance](https://www.novartis.com/investors/reporting-and-transparency-hub/esg-rating-performance "ESG rating performance")
- [Publications order form](https://www.novartis.com/news/stay-up-to-date "Publications order form")
- [ESG](https://www.novartis.com/esg "ESG")

Investors
Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.
- [News](https://www.novartis.com/news "News")
- [Newsroom](https://www.novartis.com/news/newsroom "Newsroom")
- [Media library](https://www.novartis.com/news/media-library " Media library ")
- [Stories](https://www.novartis.com/stories "Stories")
- [Subscribe](https://www.novartis.com/news/stay-up-to-date "Subscribe")
- [Events](https://www.novartis.com/events "Events")

News
Information for journalists including press releases, statements, stories, multimedia resources and more.
- [Careers](https://www.novartis.com/careers "Careers")
- [Career search](https://www.novartis.com/careers/career-search "Career search")
- [Our business functions](https://www.novartis.com/careers/our-business-functions "Our business functions")
- [Careers in research and development](https://www.novartis.com/careers/our-business-functions/careers-research-and-development "Careers in research and development")
- [Careers in operations](https://www.novartis.com/careers/our-business-functions/careers-operations "Careers in operations")
- [Careers in commercial and sales](https://www.novartis.com/careers/our-business-functions/careers-commercial-and-sales "Careers in commercial and sales")
- [Careers in global functions](https://www.novartis.com/careers/our-business-functions/careers-global-functions "Careers in global functions")
- [Why Novartis](https://www.novartis.com/careers/why-novartis "Why Novartis")
- [Career hub](https://www.novartis.com/careers/career-hub "Career hub")
- [Temporary contracts](https://novartis.willhire.co/ "Temporary contracts")
- [Early careers](https://www.novartis.com/careers/early-careers "Early careers")
- [Graduates](https://www.novartis.com/careers/early-careers/graduates "Graduates")
- [Students](https://www.novartis.com/careers/early-careers/students "Students")
- [US Biomedical Research internship programs](https://www.novartis.com/careers/early-careers/us-biomedical-research-internship-programs "US Biomedical Research internship programs")
- [Community exploration and learning lab (CELL)](https://www.novartis.com/careers/early-careers/community-exploration-and-learning-lab-cell "Community exploration and learning lab (CELL)")

Careers
Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.
- [Clinical trials](https://www.novartis.com/clinicaltrials "Clinical trials")
- [Partnering](https://www.novartis.com/partnering "Partnering")
- [Supplier portal](https://www.novartis.com/supplier-portal "Supplier portal")
- [Report side effects](https://www.novartis.com/report "Report side effects")
- [Contacts](https://www.novartis.com/contacts "Contacts")

Home
Working together, we can reimagine medicine to improve and extend people’s lives.
Header

# Careers at Novartis
## Welcome to where we thrive together
Improving the lives of people living with disease takes more than innovative science. It takes a focus on the needs of people and a community committed to meeting them. It takes a team of people like you. Working together. Learning together. Thriving together. Discover how you can join us in changing people’s lives.
## Our business functions
Learn more about our teams – what they do, how they work and where you could make a difference.
[ Research & Development Turning breakthrough science into life-changing treatments.](https://www.novartis.com/careers/our-business-functions/careers-research-and-development)
[ Operations Creating meaningful impact through best-in-class products, services, and solutions.](https://www.novartis.com/careers/our-business-functions/careers-operations)
[ Commercial & Sales Making our innovative products more widely accessible and bringing them to patients faster.](https://www.novartis.com/careers/our-business-functions/careers-commercial-and-sales)
[ Global Functions Shaping our future as a focused innovative medicines company.](https://www.novartis.com/careers/our-business-functions/careers-global-functions)
[Explore all opportunities](https://www.novartis.com/careers/career-search)
***

# Work with purpose
Chasing breakthroughs, transforming processes, or building partnerships - what you do here makes a difference.
[Learn more](https://www.novartis.com/careers/why-novartis "Learn more")

# Personal growth
You'll have countless opportunities to develop, whether it’s up, across or outside your comfort zone.
[Learn more](https://www.novartis.com/careers/why-novartis "Learn more")

# Mental health
Access advice and support to help you be your best self.
[Learn more](https://www.novartis.com/careers/why-novartis "Learn more")
[Previous](https://www.novartis.com/careers#paragraph--434321) [Next](https://www.novartis.com/careers#paragraph--434321)
[ Students and graduates Discover how you can build a brighter future with our early career opportunities.](https://www.novartis.com/careers/early-careers)
[ Get set to apply Find out what to expect during your application process and beyond.](https://www.novartis.com/careers/career-hub)
[ Job search Explore our opportunities and see where you could make the biggest impact.](https://www.novartis.com/careers/career-search)
[ People and Organization Commitment Statement Learn about our public commitments related to our people and organization, demonstrating our dedication to our workforce and supporting Novartis’ mission and values.](https://www.novartis.com/sites/novartis_com/files/people-organization-commitment-statement.pdf)

## “How do I grow? By sharing knowledge, ideas, and inspiration everyday with my incredible colleagues around the globe.”
**Dalia**, Head Data Science, Analytics and AI
***
## Benefits and rewards
Here is a glimpse of just some ways we’ll help you thrive personally and professionally.
*Specifics may vary by location*
[ Competitive pay Market-benchmarked salary ranges, with an offer reflecting your experience and skills.](https://www.novartis.com/sites/novartis_com/files/novartis-life-handbook.pdf#page=6)
[ Recognition programs Celebrate your colleagues’ personal milestones and recognize each other’s contributions. Send engaging e-cards or award monetary points for personal use or charitable donations.](https://www.novartis.com/sites/novartis_com/files/novartis-life-handbook.pdf#page=9)
[ Market competitive incentives Be rewarded for individual and company impact through our competitively benchmarked annual bonus and long-term equity share programs.](https://www.novartis.com/sites/novartis_com/files/novartis-life-handbook.pdf#page=8)
[ Generous parental leave Following the birth or adoption of a child, we offer at least 14 weeks paid parental leave to every new parent at Novartis.](https://www.novartis.com/sites/novartis_com/files/novartis-life-handbook.pdf#page=9)
[ Health and wellbeing We offer medical and life insurance as well as benefits to support your overall wellbeing.](https://www.novartis.com/sites/novartis_com/files/novartis-life-handbook.pdf#page=20)
[ Professional and leadership development Access thousands of courses, tools and resources, including coaching opportunities and internal talent and learning platforms.](https://www.novartis.com/sites/novartis_com/files/novartis-life-handbook.pdf#page=13)
## Latest stories
Unique insights and perspectives from people across Novartis.
Previous
Next
[ Building the Future: Novartis Innovation Lab - AI, Game Studio, XR & Emerging Tech The leaders behind the Novartis Innovation Lab share how they are leveraging emerging technologies to win for patients.](https://www.novartis.com/stories/building-future-novartis-innovation-lab-ai-game-studio-xr-emerging-tech)
[ Supercharging R\&D: How AI helps us to bring medicines to patients faster Max leads AI innovation in pharmaceutical development at Novartis. His story reflects how cutting-edge technology is combined with human expertise for meaningful impact.](https://www.novartis.com/stories/supercharging-rd-how-ai-helps-us-bring-medicines-patients-faster)
[ Turning personal experience into purpose-driven careers What drives someone to dedicate their career to reimagining medicine? Three women at Novartis share their deeply personal and unique stories.](https://www.novartis.com/stories/turning-personal-experience-purpose-driven-careers)
[ Science in Motion: Autumn and Sabrina's Noteworthy Novartis Adventure In the ever-evolving world of STEM, where innovation and discovery are to the forefront, the stories of women who have made their mark are both inspiring and essential. Today, we're shining a spotlight on two dedicated Novartis employees who have chosen to begin their careers in manufacturing operations, paving the way for others to follow.](https://www.novartis.com/stories/science-motion-autumn-and-sabrinas-noteworthy-novartis-adventure)
[ Parental leave – A leadership opportunity We believe in the importance of balancing professional and personal responsibilities. This belief is embodied through our inclusive parental leave policy, which supports all our people in taking the time they need to be with their families during significant life events. Sumeet shares his personal experience.](https://www.novartis.com/stories/parental-leave-leadership-opportunity)
[ Biologist to Head-hunter Sharing my career journey and decision to relocate to Ireland was an opportunity to pause and reflect, strengthening my belief that change is not always easy, but it can be very rewarding.](https://www.novartis.com/stories/biologist-head-hunter)
[ Every number has a story – my journey to Novartis as a Refugee The current refugee crisis is one of the world's greatest humanitarian challenges. Svitlana shares her story of her journey to Novartis and how her work as part of the Giving and Volunteering team is opening the doors to refugees and other marginalized groups and allowing our people to make a difference by helping those who are most vulnerable.](https://www.novartis.com/stories/every-number-has-story-my-journey-novartis-refugee)
[ Is workplace inclusion really that important? We think so and here are just some of the reasons why: we believe our workplace should reflect today’s emerging workforce; every culture needs diversity to thrive; and it supports fair treatment and opportunities for all our people.](https://www.novartis.com/stories/workplace-inclusion-really-important)
[ A personal journey full circle, from curiosity about life on Earth to transformative therapies at Novartis When I was young, my interest in science initially started with the natural world and with animals. There's a BBC Nature presenter and biologist called David Attenborough who's very famous in the UK and he was a really big idol of mine.](https://www.novartis.com/stories/personal-journey-full-circle-from-curiosity-about-life-earth-transformative-therapies-novartis)
[ Balancing family life with a legal career How do you achieve a healthy work-life balance? It’s a question we often ask ourselves at Novartis. We take health and wellbeing very seriously and are committed to helping our people be at their best, at work and in life.](https://www.novartis.com/stories/balancing-family-life-legal-career)
[ Mentoring matters: how we grow together at Novartis You can be successful, as an individual or as a business, without having to do it all on your own.](https://www.novartis.com/stories/mentoring-matters-how-we-grow-together-novartis)
[ Belonging here: How Novartis helped me come out as a transgender woman When I was in my late forties, I came to the realization that I was transgender. I signed up with a transgender clinic in Basel and went through a period of counselling.](https://www.novartis.com/stories/belonging-here-how-novartis-helped-me-come-out-transgender-woman)

# Join our talent community
Be first to hear about our latest career opportunities, news and events.
[Join our community](https://novartis.wd3.myworkdayjobs.com/Internal_Careers_for_Acquired_Entities/job/Basel-City/Novartis-Talent-Community_REQ-10067767 "Join our community")

## Be aware of fake job advertisements and job offers
Novartis is aware of employment scams which make false use of our company name or leader’s names to defraud job seekers. Novartis does not make job offers without interview and never asks candidates for money.
If you have encountered a job posting or been approached with a job offer that you suspect may be fraudulent, we strongly recommend you do not respond, send money or personal information.
Novartis in not responsible for any claims, losses, damages, or expenses resulting from scams.
[Search jobs](https://www.novartis.com/careers/career-search "Search jobs")
## **Follow Novartis careers**
Keep up with everything careers-related via our dedicated social media channels.
[LinkedIn](https://www.linkedin.com/company/novartis)
[YouTube](https://www.youtube.com/channel/UCw671bjnadQQV0UnV0DdsMQ)
[Facebook](https://www.facebook.com/novartiscareers)
[Instagram](https://www.instagram.com/novartiscareers/)
No matches found
Search
## Novartis
Working together
Working together
- [Patients and caregivers](https://www.novartis.com/patients-and-caregivers)
- [Healthcare professionals](https://www.novartis.com/healthcare-professionals)
- [Researchers](https://www.novartis.com/research-and-development)
- [Job seekers](https://www.novartis.com/careers)
- [Journalists](https://www.novartis.com/news)
- [Investors](https://www.novartis.com/investors)
Topics
Topics
- [Access](https://www.novartis.com/esg/access)
- [ESG](https://www.novartis.com/esg)
- [SpeakUp](https://www.novartis.com/esg/ethics-risk-and-compliance/ethical-behavior/speakup)
Explore
Explore
- [Pipeline](https://www.novartis.com/research-development/novartis-pipeline)
- [Products](https://www.novartis.com/about/products)
- [Clinical trials](https://www.novartis.com/clinicaltrials)
- [Partnering](https://www.novartis.com/partnering)
- [Events](https://www.novartis.com/events)
Therapeutic areas
Therapeutic areas
- [Cardiovascular, renal and metabolic](https://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic)
- [Immunology](https://www.novartis.com/about/therapeutic-areas/immunology)
- [Neuroscience](https://www.novartis.com/about/therapeutic-areas/neuroscience)
- [Oncology](https://www.novartis.com/about/therapeutic-areas/oncology)
Footer Bottom
Footer Bottom
© 2026 Novartis AG
- [Terms of use](https://www.novartis.com/terms-use)
- [Privacy](https://www.novartis.com/privacy)
- [Cookie settings](https://www.novartis.com/careers#cookie-settings-button)
- [Contacts](https://www.novartis.com/contacts)
- [Locations](https://www.novartis.com/about/locations)
- [Site map](https://www.novartis.com/sitemap.xml)
- [Open source](https://www.novartis.com/open-source)
- [Web accessibility](https://www.novartis.com/accessibility)
[Novartis Site Directory](https://www.novartis.com/novartis-directory "Novartis Site Directory")
This site is intended for a global audience |
| Readable Markdown | ## Welcome to where we thrive together
Improving the lives of people living with disease takes more than innovative science. It takes a focus on the needs of people and a community committed to meeting them. It takes a team of people like you. Working together. Learning together. Thriving together. Discover how you can join us in changing people’s lives.
## Our business functions
Learn more about our teams – what they do, how they work and where you could make a difference.
## Work with purpose
Chasing breakthroughs, transforming processes, or building partnerships - what you do here makes a difference.
## Personal growth
You'll have countless opportunities to develop, whether it’s up, across or outside your comfort zone.
## Mental health
Access advice and support to help you be your best self.
## “How do I grow? By sharing knowledge, ideas, and inspiration everyday with my incredible colleagues around the globe.”
**Dalia**, Head Data Science, Analytics and AI
## Benefits and rewards
Here is a glimpse of just some ways we’ll help you thrive personally and professionally.
*Specifics may vary by location*
## Latest stories
Unique insights and perspectives from people across Novartis.
## Join our talent community
Be first to hear about our latest career opportunities, news and events.
## Be aware of fake job advertisements and job offers
Novartis is aware of employment scams which make false use of our company name or leader’s names to defraud job seekers. Novartis does not make job offers without interview and never asks candidates for money.
If you have encountered a job posting or been approached with a job offer that you suspect may be fraudulent, we strongly recommend you do not respond, send money or personal information.
Novartis in not responsible for any claims, losses, damages, or expenses resulting from scams.
## **Follow Novartis careers**
Keep up with everything careers-related via our dedicated social media channels. |
| Shard | 46 (laksa) |
| Root Hash | 1474769238080439646 |
| Unparsed URL | com,novartis!www,/careers s443 |